Cellspect Co., Ltd.
PrivateLast Round
VC Round
May 16, 2025
Total Funding Raised
$10.91M
Company Overview
Cellspect Co., Ltd. operates in Healthcare & Life Sciences and is based in Morioka. Its latest recorded funding round was a VC Round in May 2025.
Cellspect Co., Ltd. is a healthtech company that develops and manufactures in-vitro diagnostic reagents and medical devices, providing rapid clinical testing solutions and biomarker research services.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellspect Co., Ltd. Comparables
Compare Cellspect Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precision Biosensor | 77% | |
| Soulbrain Holdings Co. Ltd | 76% | |
| ARKRAY, Inc. | 74% |
For institutional investors. Book with your work email.
Cellspect Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 16, 2025 | ||||
| Debt | Mar 25, 2019 | ||||
| Series A | Mar 31, 2018 | ||||
| Seed | Aug 31, 2017 | ||||
| Seed | Mar 30, 2016 |
For institutional investors. Book with your work email.
Cellspect Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Bank of Iwate, Ltd. | Debt |
| 株式会社日本政策金融公庫 | Debt |
| Tokyo University of Science Innovation Capital | Series A |
| Aflac Ventures Japan | Series A |
| Mitsubishi UFJ Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 56% MoM, reaching 2.5K.
- Jan 14, 2025
Monthly visitors increased 47% MoM, reaching 2.8K.
For institutional investors. Book with your work email.
Cellspect Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellspect Co., Ltd.'s valuation, stock price, and market status.
Is Cellspect Co., Ltd. a public or private company?
Cellspect Co., Ltd. is a private company.
What is the current stock price of Cellspect Co., Ltd.?
Cellspect Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Cellspect Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellspect Co., Ltd. worth (valuation)?
Valuation information for Cellspect Co., Ltd. is not publicly available.
Can I buy Cellspect Co., Ltd. stock?
Cellspect Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellspect Co., Ltd.'s last funding round?
Cellspect Co., Ltd.'s most recent funding round was VC Round on May 16, 2025.
Who are the main investors in Cellspect Co., Ltd.?
Key investors in Cellspect Co., Ltd. include The Bank of Iwate, Ltd., 株式会社日本政策金融公庫, Tokyo University of Science Innovation Capital, Aflac Ventures Japan, Mitsubishi UFJ Capital.
Will Cellspect Co., Ltd. IPO soon?
No public IPO plans have been announced for Cellspect Co., Ltd..
How can I track Cellspect Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Cellspect Co., Ltd.'s shares on secondary markets.